TGF-β1 Suppresses IL-33–Induced Mast Cell Function

HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins

(2016) Damien Bertheloot et al.   Cellular & Molecular Immunology

Interleukin-33, friend and foe in type-2 immune responses

(2016) Clare Hardman et al.   CURRENT OPINION IN IMMUNOLOGY

Signal transduction and chemotaxis in mast cells

(2016) Petr Draber et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Interleukins (from IL-1 to IL-38), interferons, transforming growth factor β, and TNF-α: Receptors, functions, and roles in diseases

(2016) Mübeccel Akdis et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

The role of IL-33 and mast cells in allergy and inflammation

(2015) Rohit Saluja et al.   Clinical and Translational Allergy

IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy

(2014) Corinne Cayrol et al.   CURRENT OPINION IN IMMUNOLOGY

TGF- 1 Attenuates Mediator Release and De Novo Kit Expression by Human Skin Mast Cells through a Smad-Dependent Pathway

(2014) W. Zhao et al.   JOURNAL OF IMMUNOLOGY

Central domain of IL-33 is cleaved by mast cell proteases for potent activation of group-2 innate lymphoid cells

(2014) E. Lefrancais et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

SMAD regulatory networks construct a balanced immune system

(2013) Nidhi Malhotra et al.   IMMUNOLOGY

Mast Cell Chymase Degrades the Alarmins Heat Shock Protein 70, Biglycan, HMGB1, and Interleukin-33 (IL-33) and Limits Danger-induced Inflammation

(2013) Ananya Roy et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Genotype-Dependent Effects of TGF- 1 on Mast Cell Function: Targeting the Stat5 Pathway

(2013) J. Fernando et al.   JOURNAL OF IMMUNOLOGY

Genetic Polymorphism of Transforming Growth Factor  1 and Tumor Necrosis Factor   Is Associated With Asthma and Modulates the Severity of Asthma

(2013) C.-H. Chiang et al.   Respiratory Care

Intraperitoneal influx of neutrophils in response to IL-33 is mast cell-dependent

(2012) M. Enoksson et al.   BLOOD

Mast cell chymase modulates IL-33 levels and controls allergic sensitization in dust-mite induced airway inflammation

(2012) I Waern et al.   Mucosal Immunology

The TGFbeta Superfamily Signaling Pathway

(2012) Alexander Weiss et al.   Wiley Interdisciplinary Reviews-Developmental Biology

Resolution of Allergic Inflammation and Airway Hyperreactivity Is Dependent upon Disruption of the T1/ST2–IL-33 Pathway

(2009) Jennifer Kearley et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma

(2009) Xiaojin Liu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Developmental plasticity of Th17 and Treg cells

(2009) Yun Kyung Lee et al.   CURRENT OPINION IN IMMUNOLOGY

Anti-inflammatory and pro-inflammatory roles of TGF-β, IL-10, and IL-22 in immunity and autoimmunity

(2009) Shomyseh Sanjabi et al.   CURRENT OPINION IN PHARMACOLOGY

IL-33 synergizes with IgE-dependent and IgE-independent agents to promote mast cell and basophil activation

(2009) Matthew R. Silver et al.   INFLAMMATION RESEARCH

IL-33 Amplifies the Polarization of Alternatively Activated Macrophages That Contribute to Airway Inflammation

(2009) M. Kurowska-Stolarska et al.   JOURNAL OF IMMUNOLOGY

Increased Expression of IL-33 in Severe Asthma: Evidence of Expression by Airway Smooth Muscle Cells

(2009) D. Prefontaine et al.   JOURNAL OF IMMUNOLOGY

FOXP3 and the regulation of Treg/Th17 differentiation

(2009) Steven F. Ziegler et al.   MICROBES AND INFECTION

TGFB1 promoter polymorphism C-509T and pathophysiology of asthma

(2007) Tetsuya Ueda et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY